☰

Susana De La Luna - Publications

Affiliations: 
Centre for Genomic Regulation (CRG), Spain 
Tree Info Grants Similar researchers PubMed Report error

23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Di Vona C, Barba L, Ferrari R, de la Luna S. Loss of the DYRK1A Protein Kinase Results in the Reduction in Ribosomal Protein Gene Expression, Ribosome Mass and Reduced Translation. Biomolecules. 14. PMID 38254631 DOI: 10.3390/biom14010031  0.431
2023 Jiménez-Izquierdo R, Morrugares R, Suanes-Cobos L, Correa-Sáez A, Garrido-Rodríguez M, Cerero-Tejero L, Khan OM, de la Luna S, Sancho R, Calzado MA. FBXW7 tumor suppressor regulation by dualspecificity tyrosine-regulated kinase 2. Cell Death & Disease. 14: 202. PMID 36934104 DOI: 10.1038/s41419-023-05724-0  0.485
2021 Lara-Chica M, Correa-Sáez A, Jiménez-Izquierdo R, Garrido-Rodríguez M, Ponce FJ, Moreno R, Morrison K, Di Vona C, Arató K, Jiménez-Jiménez C, Morrugares R, Schmitz ML, de la Luna S, de la Vega L, Calzado MA. A novel CDC25A/DYRK2 regulatory switch modulates cell cycle and survival. Cell Death and Differentiation. PMID 34363019 DOI: 10.1038/s41418-021-00845-5  0.514
2020 Boni J, Rubio-Perez C, López-Bigas N, Fillat C, de la Luna S. The DYRK Family of Kinases in Cancer: Molecular Functions and Therapeutic Opportunities. Cancers. 12. PMID 32751160 DOI: 10.3390/cancers12082106  0.512
2020 Boni J, Rubio-Perez C, López-Bigas N, Fillat C, de la Luna S. The DYRK Family of Kinases in Cancer: Molecular Functions and Therapeutic Opportunities. Cancers. 12. PMID 32751160 DOI: 10.3390/cancers12082106  0.512
2019 Roewenstrunk J, Di Vona C, Chen J, Borras E, Dong C, Arató K, Sabidó E, Huen MSY, de la Luna S. A comprehensive proteomics-based interaction screen that links DYRK1A to RNF169 and to the DNA damage response. Scientific Reports. 9: 6014. PMID 30979931 DOI: 10.1038/s41598-019-42445-x  0.424
2019 Luna J, Boni J, Cuatrecasas M, Bofill-De Ros X, Núñez-Manchón E, Gironella M, Vaquero EC, Arbones ML, de la Luna S, Fillat C. DYRK1A modulates c-MET in pancreatic ductal adenocarcinoma to drive tumour growth. Gut. 68: 1465-1476. PMID 30343272 DOI: 10.1136/gutjnl-2018-316128  0.312
2019 Luna J, Boni J, Cuatrecasas M, Bofill-De Ros X, Núñez-Manchón E, Gironella M, Vaquero EC, Arbones ML, de la Luna S, Fillat C. DYRK1A modulates c-MET in pancreatic ductal adenocarcinoma to drive tumour growth. Gut. 68: 1465-1476. PMID 30343272 DOI: 10.1136/gutjnl-2018-316128  0.312
2018 Rozen EJ, Roewenstrunk J, Barallobre MJ, Di Vona C, Jung C, Figueiredo AF, Luna J, Fillat C, Arbonés ML, Graupera M, Valverde MA, de la Luna S. DYRK1A Kinase Positively Regulates Angiogenic Responses in Endothelial Cells. Cell Reports. 23: 1867-1878. PMID 29742440 DOI: 10.1016/j.celrep.2018.04.008  0.349
2015 Di Vona C, Bezdan D, Islam AB, Salichs E, López-Bigas N, Ossowski S, de la Luna S. Chromatin-wide profiling of DYRK1A reveals a role as a gene-specific RNA polymerase II CTD kinase. Molecular Cell. 57: 506-20. PMID 25620562 DOI: 10.1016/J.Molcel.2014.12.026  0.436
2014 Grau C, Arató K, Fernández-Fernández JM, Valderrama A, Sindreu C, Fillat C, Ferrer I, de la Luna S, Altafaj X. DYRK1A-mediated phosphorylation of GluN2A at Ser(1048) regulates the surface expression and channel activity of GluN1/GluN2A receptors. Frontiers in Cellular Neuroscience. 8: 331. PMID 25368549 DOI: 10.3389/fncel.2014.00331  0.414
2011 Papadopoulos C, Arato K, Lilienthal E, Zerweck J, Schutkowski M, Chatain N, Müller-Newen G, Becker W, de la Luna S. Splice variants of the dual specificity tyrosine phosphorylation-regulated kinase 4 (DYRK4) differ in their subcellular localization and catalytic activity. The Journal of Biological Chemistry. 286: 5494-505. PMID 21127067 DOI: 10.1074/jbc.M110.157909  0.519
2011 Aranda S, Laguna A, de la Luna S. DYRK family of protein kinases: evolutionary relationships, biochemical properties, and functional roles. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 25: 449-62. PMID 21048044 DOI: 10.1096/fj.10-165837  0.65
2010 Ferron SR, Pozo N, Laguna A, Aranda S, Porlan E, Moreno M, Fillat C, de la Luna S, Sánchez P, Arbonés ML, Fariñas I. Regulated segregation of kinase Dyrk1A during asymmetric neural stem cell division is critical for EGFR-mediated biased signaling. Cell Stem Cell. 7: 367-79. PMID 20804972 DOI: 10.1016/j.stem.2010.06.021  0.618
2009 Martínez-Martínez S, Genescà L, Rodríguez A, Raya A, Salichs E, Were F, López-Maderuelo MD, Redondo JM, de la Luna S. The RCAN carboxyl end mediates calcineurin docking-dependent inhibition via a site that dictates binding to substrates and regulators. Proceedings of the National Academy of Sciences of the United States of America. 106: 6117-22. PMID 19332797 DOI: 10.1073/pnas.0812544106  0.4
2008 Laguna A, Aranda S, Barallobre MJ, Barhoum R, Fernández E, Fotaki V, Delabar JM, de la Luna S, de la Villa P, Arbonés ML. The protein kinase DYRK1A regulates caspase-9-mediated apoptosis during retina development. Developmental Cell. 15: 841-53. PMID 19081073 DOI: 10.1016/j.devcel.2008.10.014  0.625
2008 Aranda S, Alvarez M, Turró S, Laguna A, de la Luna S. Sprouty2-mediated inhibition of fibroblast growth factor signaling is modulated by the protein kinase DYRK1A. Molecular and Cellular Biology. 28: 5899-911. PMID 18678649 DOI: 10.1128/MCB.00394-08  0.67
2007 Alvarez M, Altafaj X, Aranda S, de la Luna S. DYRK1A autophosphorylation on serine residue 520 modulates its kinase activity via 14-3-3 binding. Molecular Biology of the Cell. 18: 1167-78. PMID 17229891 DOI: 10.1091/mbc.E06-08-0668  0.66
2006 de la Luna S, Estivill X. Cooperation to amplify gene-dosage-imbalance effects. Trends in Molecular Medicine. 12: 451-4. PMID 16919501 DOI: 10.1016/J.Molmed.2006.08.001  0.356
2003 Alvarez M, Estivill X, de la Luna S. DYRK1A accumulates in splicing speckles through a novel targeting signal and induces speckle disassembly. Journal of Cell Science. 116: 3099-107. PMID 12799418 DOI: 10.1242/Jcs.00618  0.476
2003 Martí E, Altafaj X, Dierssen M, de la Luna S, Fotaki V, Alvarez M, Pérez-Riba M, Ferrer I, Estivill X. Dyrk1A expression pattern supports specific roles of this kinase in the adult central nervous system. Brain Research. 964: 250-63. PMID 12576186 DOI: 10.1016/S0006-8993(02)04069-6  0.392
2000 Fuentes JJ, Genescà L, Kingsbury TJ, Cunningham KW, Pérez-Riba M, Estivill X, de la Luna S. DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways. Human Molecular Genetics. 9: 1681-90. PMID 10861295 DOI: 10.1093/Hmg/9.11.1681  0.303
1999 de la Luna S, Allen KE, Mason SL, La Thangue NB. Integration of a growth-suppressing BTB/POZ domain protein with the DP component of the E2F transcription factor. The Embo Journal. 18: 212-28. PMID 9878064 DOI: 10.1093/emboj/18.1.212  0.39
Show low-probability matches.